Shanti Inorgan, a company in the Commodity Chemicals industry, reported revenue of ₹54 crore and net profit of ₹7.00 crore for the September 2026 quarter.
Shanti Inorgan. (NSE: SHANTIINOR-SM) closed at ₹199.50 on 20 Nov 2026. Its market capitalisation is ₹344 crore and it trades at 33.8 times earnings.
Incorporated in January 2010, Shanti Inorganics Ltd. manufactures and trades sulfur-based inorganic chemicals.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.